NDC 51662-1326
2% Lidocaine Hci 20 mg per 1 mL injection, solution
On the label: HF Acquisition Co. LLC. DBA HealthFirst. It's repackaged: HF Acquisition Co. LLC. DBA HealthFirst rebottles it from Hospira, Inc.'s NDC 0409-4277.
Where the pills inside were made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Hospira, Inc. | Rocky Mount, NC, United States | Makes it, tests it, packages it and labels it | No problems foundFeb 7, 2025 · 11 inspections, 3 with FDA action |
| Pfizer Healthcare India Private Limited | Anakapalli, India | Makes it, tests it, packages it and labels it | Problems found, fixed voluntarilyOct 18, 2022 · 7 inspections, 1 with FDA action |
| Hospira, Inc. | McPherson, KS, United States | Tests it | Problems found, fixed voluntarilyJan 17, 2025 · 16 inspections, 2 with FDA action |
Repackaging site
- HF Acquisition Co LLC, Mukilteo, WA, United States · relabels it
Product details
- Generic drug
- Lidocaine: every company that makes it
- Form
- injection, solution, infiltration; perineural
- Strength
- 20 mg per 1 mL
- Approval
- ANDA ANDA088327
- On the market since
- Oct 22, 2018
- Package NDCs
51662-1326-151662-1326-251662-1326-3- Official label
- DailyMed (National Library of Medicine), updated Jan 28, 2024
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?